Eli Lilly (NYSE:LLY) yesterday dosed the first patient in a trial of its automated insulin delivery system. The system is a hybrid closed-loop platform that includes a connected insulin pump, a dosing algorithm and a continuous glucose monitor. Get the full story at our sister site, Drug Delivery Business News.
Drug-Device Combinations
Dance Biopharm, Phillips-Medisize ink deal for inhaled insulin device
Privately-held biotech Dance Biopharm and Phillips-Medisize have entered into a joint development deal for a connected drug-delivery device for inhaled insulin. The agreement gives Phillips-Medisize, which already designs and manufactures devices for Dance, the development work for future enhancements of Dance’s devices, as well as commercial manufacturing of the inhaled insulin delivery device when it gets to the market. […]
Silicone patch for laser-assisted tattoo removal wins new FDA clearance
Merz North America said today that its Describe PFD patch was cleared by the FDA for all commonly-used lasers. The single-use, perfluorodecalin-infused patch is used during laser-assisted tattoo removal to allow for multiple passes in a single treatment session. Get the full story at our sister site, Drug Delivery Business News.
Sanofi touts head-to-head comparison of long-acting insulin products
Sanofi‘s (NYSE:SNY) long-acting insulin glargine, Toujeo, met the primary objective of a head-to-head trial comparing it to Novo Nordisk‘s (NYSE:NVO) insulin degludec, Tresiba, the company reported today. The insulin-maker said it plans to report full results from the Bright trial sometime next year. The study’s primary objective was to determine if Toujeo had a similar effect […]
CareFusion warns customers about Alaris syringe pump alarm
CareFusion issued a warning to customers of its Alaris syringe drug pump system, cautioning them that pumps made before 2008 may display an error message that could stop the pump from working. The company wrote that it has received a report from a customer that the device displayed a re-occurring internal malfunction error code, PL3, which […]
Novocure nabs reimbursement for Optune in Japan
Novocure (NSDQ:NVCR) shares were up this morning after the Japanese Ministry of Health, Labour and Welfare agreed to reimburse for Optune as a treatment for newly-diagnosed glioblastoma. The Optune device delivers low-intensity, intermediate frequency, alternating electric fields, called “Tumor Treating Fields,” to inhibit cancer cell replication. As a treatment for newly-diagnosed glioblastoma, Novocure combines its device with the […]
Smith & Nephew deals topical anesthetic gel to Alliance Pharma
Alliance Pharma (LON:APH) has acquired the rights to Smith & Nephew‘s (NYSE:SNN) anesthetic gel Ametop for $7.5 million, according to the specialty pharmaceutical company. The product, which Smith & Nephew has been selling in the U.K., Ireland, New Zealand and Canada for at least 10 years, is designed to numb a patient’s skin before an injection. Get the […]
FDA’s Gottlieb updates on Puerto Rico and medical product shortages
FDA commissioner Dr. Scott Gottlieb provided an update today to the work that the agency is doing to help medical device manufacturers in Puerto Rico in the weeks following Hurricanes Irma and Maria. The FDA chief noted that even though some major medical product manufacturers have regained power, many firms continue to run on generator […]
Flexion CEO: Setting Zilretta up to succeed with a history lesson
Locally acting therapies are like a religion to Flexion Therapeutics (NSDQ:FLXN) co-founder & CEO Dr. Mike Clayman, who spent decades at Eli Lilly (NYSE:LLY) with the company’s co-founder, Dr. Neil Bodick, watching promising compounds fail in late-stage trials on the heels of unanticipated safety results. “That’s part of the reason, not the whole reason but part of the reason, […]
FDA approves first once-monthly buprenorphine injection to treat opioid addiction
Indivior (LON:INDV) shares jumped today after the FDA approved its once-monthly buprenorphine injection for the treatment of opioid addiction in adult patients who have started therapy with a transmucosal buprenorphine product. The company’s once-monthly injection is the first medication-assisted treatment option of its kind, the regulatory agency touted. Before Indivior’s Sublocade was approved, all other available […]
Ascensia Diabetes Care highlights women helping to advance diabetes care
In support of World Diabetes Day earlier this month, Ascensia Diabetes Care published 30 portraits of women who are working to advance diabetes care. The company’s CEO, Michael Kloss, said he was inspired by the theme of this year’s annual event, Women and Diabetes, and turned within the company for nominations of inspiring women. Get the full story […]